WeVote
Log In

Bill

Bill

HB 1741

Expanding access to treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome.

2025-2026 Regular Session Introduced by Travis Couture and 9 co-sponsors

Washington bill expands patient access to PANDAS/PANS diagnosis and treatment, potentially increasing insurance coverage for these contested pediatric neuropsychiatric conditions.

First reading, referred to Health Care & Wellness.
0
WeVote Research Nonpartisan
Bill Summary · HB 1741

Legislative bill overview

HB 1741 expands access to treatment for PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections) and PANS (Pediatric Acute-Onset Neuropsychiatric Syndrome) in Washington state. The bill likely aims to improve diagnosis, insurance coverage, and treatment options for children experiencing sudden-onset neuropsychiatric symptoms potentially linked to infections or immune dysfunction.

Why is this important

PANDAS and PANS are controversial diagnoses where children develop rapid behavioral, psychological, or neurological changes that some believe are triggered by infections or immune dysfunction. Expanding access could help affected families obtain treatment and insurance reimbursement, though current medical evidence remains limited and contested. This affects both the children and families seeking care and healthcare policy regarding experimental or disputed treatments.

Potential points of contention

  • Medical consensus gap: PANDAS/PANS lack clear diagnostic criteria and broad acceptance in mainstream pediatric neurology and psychiatry, creating tension between patient advocacy and evidence-based medical standards
  • Insurance and treatment costs: Expanding coverage could significantly increase healthcare expenses if treatments are approved without strong clinical trial data supporting efficacy
  • Definition and scope creep: Broad definitions of PANS could result in misdiagnosis of children with other treatable conditions (anxiety, OCD, other psychiatric disorders) as immune-related problems

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.